| scholarly article | Q13442814 |
| P2093 | author name string | Shannon K | |
| French G | |||
| King A | |||
| May J | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| P304 | page(s) | 189-197 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Glycopeptide tolerance in Staphylococcus aureus. | |
| P478 | volume | 42 |
| Q42548244 | "Tolerance" of misused terminology? Enforcing standardized phenotypic definitions. |
| Q41005454 | Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy. |
| Q88924617 | Antibacterial and Cytotoxic Potential of Biosynthesized Silver Nanoparticles by Some Plant Extracts |
| Q54026614 | Antibiotic resistance in Gram-positive cocci. |
| Q92339898 | Antioxidant, cytotoxic and antibacterial potential of biosynthesized nanoparticles using bee honey from two different floral sources in Saudi Arabia |
| Q35078077 | Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome |
| Q38920223 | Beyond conventional antibiotics - New directions for combination products to combat biofilm |
| Q94453085 | Biogenic synthesis of silver nanoparticles: Antibacterial and cytotoxic potential |
| Q35782816 | Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). |
| Q34721715 | Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin |
| Q37666679 | Effect of United States buckwheat honey on antibiotic-resistant hospital acquired pathogens. |
| Q36589009 | Eugenol Provokes ROS-Mediated Membrane Damage-Associated Antibacterial Activity Against Clinically Isolated Multidrug-Resistant Staphylococcus aureus Strains |
| Q36422529 | From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. |
| Q35752864 | Glycopeptide antibiotics: from conventional molecules to new derivatives |
| Q36072225 | Glycopeptide resistance in gram-positive cocci: a review |
| Q48202873 | History of antibiotics: from fluoroquinolones to daptomycin (Part 2). |
| Q54373227 | In vitro antibacterial activity of nanoconjugated vancomycin against plasmid mediated intraspecies and interspecies transfer of vancomycin resistance. |
| Q42948712 | In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates |
| Q38154186 | Industrial natural product chemistry for drug discovery and development. |
| Q37190789 | Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007. |
| Q44682720 | Investigation of methicillin-resistant Staphylococcus aureus showing reduced vancomycin susceptibility isolated from a patient with infective endocarditis |
| Q44653868 | Is Methicillin-Resistant Staphylococcus aureus More Virulent than Methicillin-Susceptible S. aureus? A Comparative Cohort Study of British Patients with Nosocomial Infection and Bacteremia |
| Q35013754 | Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model |
| Q44705813 | Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model |
| Q40327518 | Loss of function of the gdpP protein leads to joint β-lactam/glycopeptide tolerance in Staphylococcus aureus. |
| Q58606414 | Magnetic Nanoconjugated Teicoplanin: A Novel Tool for Bacterial Infection Site Targeting |
| Q34590133 | Microbial epidemiology patterns of surgical infection pathogens |
| Q61454960 | Neo-5,22-Cholestadienol Derivatives from Karsch and Targeted Bactericidal Action Mechanisms |
| Q39476658 | Pharmacokinetics of a new parenteral oligosaccharide antibiotic, SCH27899 (Ziracin), in healthy subjects |
| Q42170761 | Possible role of sarA in dehydroepiandrosterone-mediated increase in Staphylococcus aureus resistance to vancomycin |
| Q38780029 | Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia |
| Q34783668 | Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia |
| Q34589936 | Role of glycopeptides in the treatment of septic complications after cardiac surgery |
| Q35628948 | Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse |
| Q24234764 | Teicoplanin versus vancomycin for proven or suspected infection |
| Q34091829 | The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia. |
| Q42743427 | Tolerance and heteroresistance in Gram-positive microorganisms |
| Q41813830 | Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci |
| Q46515401 | Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study |
| Q40470302 | Vancomycin tolerance in enterococci. |
| Q40483972 | Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer |
| Q35203343 | Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening |
| Q36839712 | Vancomycin: does it still have a role as an antistaphylococcal agent? |
| Q73714190 | [Glycopeptides] |
Search more.